Navigation Links
FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Date:10/27/2008

nvironment in the markets where we operate; our exposure to product liability and other lawsuits and contingencies; the increasing cost of insurance and the availability of product liability insurance coverage; our timely and successful completion of strategic initiatives, including integrating companies (such as PLIVA d.d.) and products we acquire; fluctuations in operating results, including the effects on such results from spending for research and development, sales and marketing activities and patent challenge activities; the inherent uncertainty associated with financial projections; our expansion into international markets through our PLIVA acquisition, and the resulting currency, governmental, regulatory and other risks involved with international operations; our ability to service our significantly increased debt obligations as a result of the PLIVA acquisition; changes in generally accepted accounting principles; the reactions of the Company's customers and suppliers to the merger; and diversion of management time on merger-related issues. These and other applicable risks, cautionary statements and factors that could cause actual results to differ from the Company's forward-looking statements are included in the Company's filings with the U.S. Securities and Exchange Commission ("SEC"), specifically as described in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2007. The Company undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances.

Important Legal Information

In connection with the proposed merger, the Company will prepare a proxy statement to be filed with the SEC. When completed, a definitive proxy statement and a form of proxy will be mailed to the stockholders of the Company. Before making any voting decision, the Company's stockholders are urged to read the proxy statement regarding the merger carefully and in its entirety because it wil
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
2. FDA Approves Orphan Drug Status for Revolutionary Cancer Drug for Children
3. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
4. FDA Approves Fougeras Clotrimazole Cream USP 1%
5. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
6. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
7. Signalife Board Approves Merger
8. FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
9. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
10. FDA Approves ACIPHEX(R) (rabeprazole sodium) 20 mg for Short-Term Treatment of GERD in Adolescents
11. FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Ky. (PRWEB) March 03, 2015 Experts ... their schedules for one event: the Alltech REBELation exploring ... from May 17-20. Now in its 31st year, Alltech’s ... from 70 countries, and the opportunity to join the ... March 7 at 11:59 p.m. EST, at which point ...
(Date:3/3/2015)... Adaptive Biotechnologies announced today that Chad ... of Director as Chair of the Audit Committee. ... oversees all finance, treasury and accounting functions. Since joining ... treasury and accounting functions, and led the finance organization ... he was named Puget Sound Business Journal,s CFO of ...
(Date:3/3/2015)... The winners of awards for supply chain resilience ... Global Supply Chain Resiliency Council (GSCRC) at the ... 25th, 2015, at the Hyatt Regency in Santa Clara, ... supply chain risk management and resiliency practitioners with luminaries ... opportunities to collaborate, develop and share best practices, and ...
(Date:3/3/2015)... AtheroNova Inc. (OTCQB: AHRO) today announced that the Company and ... 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy ... Santa Ana division (the "Bankruptcy Court") on ... to be jointly administered. The Company will evaluate ... for all or substantially all of its assets to a ...
Breaking Biology Technology:World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors 2Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 2AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 4
... Sigma-Aldrich Corporation (Nasdaq: SIAL ) will be presenting at the Baird,s 2010 ... CDT ( 2:15 PM EDT ) in Chicago, IL.  Interested ... http://investor.sigmaaldrich.com/ .  Users can click the "Webcast" icon to access this file.   ... About Sigma-Aldrich: ...
... May 17 Three years of teamwork between Elekta ... University Heavy Ion Medical Center used carbon ion radiotherapy to treat a ... use of Elekta,s treatment planning software, XiO® , for delivery with ... , , ...
... May 17 Eli Lilly and Company will unveil data ... of Clinical Oncology (ASCO) in Chicago, Ill. from June ... latest research results on ALIMTA® (pemetrexed for injection) and GEMZAR® (gemcitabine HCl ... Merck-Serono.   , , , ...
Cached Biology Technology:Sigma-Aldrich Corporation to Present at the Baird's 2010 Growth Stock Conference on Thursday, May 20, 2010 2Elekta / Mitsubishi Electric Collaboration Helps Japan's Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer 2Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 2Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 3Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 4Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 5Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 6Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 7Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 8Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 9Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 10Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 11Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 12Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010 13
(Date:2/5/2015)... 26, 2015   Epic Sciences , a precision diagnostics ... that Murali Prahalad , Ph.D., president and CEO, is ... (PMWC) 2015: Silicon Valley, which is taking place at ... on January 26-28, 2015. Dr. ... as Biomarkers." Last year, Epic Sciences was a finalist in ...
(Date:2/5/2015)... , Jan. 28, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... the upcoming RedChip Global Online CEO Conference on January ... Gino Pereira , CEO of NXT-ID will ... lead product, the Wocket smart wallet and its full ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... As nations from around the world meet in Copenhagen from ... Change, researchers from the University of Delaware are taking a ... on Oceans, Coasts, and Islands, housed at UD, is being ... world,s oceans. Oceans Day, to be held Dec. ...
... they pop the champagne corks to celebrate New Year,s Eve, ... behind them. That,s because pharmaceutical companies who make top-selling drugs ... tough year in the midst of mounting market pressures and ... of the pharmaceutical industry is scheduled for the current issue ...
... published this week in the journal Proceedings of the ... structure and function of a key player in regulating chromatin ... assistant professor of medical genetics and a scientist at The ... Family Research Institute. Chromatin, a dynamic DNA-protein complex, is ...
Cached Biology News:Oceans day at International Climate Change Conference 2
... Source of colony stimulating factors for ... marrow, spleen, blood and fetal liver. ... CFU-M, CFU-G and CFU-GEMM when added to ... with addition of erythropoietin. Will also ...
ImmunoPure Plus Immobilized Protein G, , , , Support: Cross-linked 6%, beaded agarose , Capacity: > 20 mg human IgG/ml of gel ...
...
... The Infinite 200 series of microplate readers ... absorbance detection in an affordable, easy-to-use platform ... applications. The unique modular design and adaptability ... with a choice of a monochromator (M200) ...
Biology Products: